Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Parisi

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
Journal of Clinical Microbiology|December 8, 2005
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapyLoredana Sarmati, Saverio Giuseppe Parisi, Emanuele Nicastri, et al.
Journal of Cardiovascular Development and Disease|January 26, 2018
A Multiparametric Approach Based on NT-proBNP, ST2, and Galectin3 for Stratifying One Year Prognosis of Chronic Heart Failure OutpatientsDario Grande, Marta Leone, Caterina Rizzo, et al.
BMC Infectious Diseases|July 13, 2013
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjectsSaverio Giuseppe Parisi, Samantha Andreis, Carlo Mengoli, et al.
Blood|October 8, 2005
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel clusterSilverio Perrotta, Bruno Nobili, Marcella Ferraro, et al.
Vaccines|April 28, 2023
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral TherapyIlaria Vicenti, Monica Basso, Nicole Pirola, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Fluoroquinolones and Biofilm: A Narrative ReviewNicholas Geremia, Federico Giovagnorio, Agnese Colpani, et al.
BMC Infectious Diseases|June 28, 2015
Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014Saverio Giuseppe Parisi, Andrea Bartolini, Erica Santacatterina, et al.
Expert Review of Anticancer Therapy|August 1, 2012
Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice?Rodolfo Sacco, Irene Bargellini, Barbara Ginanni, et al.
Vaccines|January 21, 2023
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive PatientsMonica Basso, Nicole Pirola, Susanna Pascoli, et al.
Viruses|August 26, 2023
Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter StudyMonica Basso, Giuliana Battagin, Stefano Nicolè, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Journal of Clinical Microbiology|December 8, 2005
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapyLoredana Sarmati, Saverio Giuseppe Parisi, Emanuele Nicastri, et al.
Journal of Cardiovascular Development and Disease|January 26, 2018
A Multiparametric Approach Based on NT-proBNP, ST2, and Galectin3 for Stratifying One Year Prognosis of Chronic Heart Failure OutpatientsDario Grande, Marta Leone, Caterina Rizzo, et al.
BMC Infectious Diseases|July 13, 2013
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjectsSaverio Giuseppe Parisi, Samantha Andreis, Carlo Mengoli, et al.
Blood|October 8, 2005
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel clusterSilverio Perrotta, Bruno Nobili, Marcella Ferraro, et al.
Vaccines|April 28, 2023
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral TherapyIlaria Vicenti, Monica Basso, Nicole Pirola, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Fluoroquinolones and Biofilm: A Narrative ReviewNicholas Geremia, Federico Giovagnorio, Agnese Colpani, et al.
BMC Infectious Diseases|June 28, 2015
Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014Saverio Giuseppe Parisi, Andrea Bartolini, Erica Santacatterina, et al.
Expert Review of Anticancer Therapy|August 1, 2012
Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice?Rodolfo Sacco, Irene Bargellini, Barbara Ginanni, et al.
Vaccines|January 21, 2023
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive PatientsMonica Basso, Nicole Pirola, Susanna Pascoli, et al.
Viruses|August 26, 2023
Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter StudyMonica Basso, Giuliana Battagin, Stefano Nicolè, et al.
Pageof 13